Epsilon M&A Deal Report - Direct Healthcare (Chemist Direct)
Transaction Multiples for the Valuation of Private Companies
Pharmacy2U / Direct Healthcare (Chemist Direct)
- Internet > e-commerce (B2C)
- Pharmaceuticals & Cosmetics R&W > Retail and Wholesale ('R&W') > Drugs Retailers
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ns | ns | ns | ns | ns | |||
Current | ns | ns |
Multiple available | |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « e-commerce (B2C) » = 277
- Number of EMAT Reports / sub-sector « Drugs Retailers » = 51
Date | Acquirer | Target | Country | Multiples | See details |
25/02/2021 | Private group led by Isatis Capital, BNP Paribas Développement | Sagitta Pharma (T&J Healthcare) | Indre-Et-Loire | * | 107980 |
04/10/2019 | Series A funding round led by Capital Croissance | Onatera (Maboutiqueonaturel) | France | * | 107706 |
Source: Epsilon Research / EMAT